Compare VCYT & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCYT | NMRK |
|---|---|---|
| Founded | 2006 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.2B |
| IPO Year | 2013 | 2017 |
| Metric | VCYT | NMRK |
|---|---|---|
| Price | $34.88 | $16.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $46.00 | $19.60 |
| AVG Volume (30 Days) | 824.1K | ★ 1.0M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ 94.50 |
| EPS | 0.38 | ★ 0.59 |
| Revenue | $495,141,000.00 | ★ $3,160,782,000.00 |
| Revenue This Year | $16.72 | $22.26 |
| Revenue Next Year | $11.31 | $9.89 |
| P/E Ratio | $94.90 | ★ $27.73 |
| Revenue Growth | 16.41 | ★ 20.95 |
| 52 Week Low | $22.61 | $9.65 |
| 52 Week High | $50.71 | $19.84 |
| Indicator | VCYT | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 27.09 | 37.27 |
| Support Level | $40.29 | $15.73 |
| Resistance Level | $38.98 | $18.01 |
| Average True Range (ATR) | 1.84 | 0.64 |
| MACD | -0.64 | -0.13 |
| Stochastic Oscillator | 0.14 | 16.87 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.